Raymond James Cuts Zimmer Biomet (NYSE:ZBH) Price Target to $128.00
Zimmer Biomet (NYSE:ZBH – Free Report) had its price objective trimmed by Raymond James from $138.00 to $128.00 in a research note issued to investors on Thursday, Benzinga reports. The brokerage currently has an outperform rating on the medical equipment provider’s stock. Several other brokerages also recently weighed in on ZBH. Evercore ISI lowered their […]
More Stories
Mastercard Incorporated (NYSE:MA) Shares Purchased by Zurcher Kantonalbank Zurich Cantonalbank
Zurcher Kantonalbank Zurich Cantonalbank boosted its position in shares of Mastercard Incorporated (NYSE:MA – Free Report) by 18.6% in the...
The Carlyle Group Inc. 4.625% Subordinated Notes due 2061 (NASDAQ:CGABL) Sees Large Growth in Short Interest
The Carlyle Group Inc. 4.625% Subordinated Notes due 2061 (NASDAQ:CGABL – Get Free Report) was the target of a significant...
Short Interest in Fujitsu Limited (OTCMKTS:FJTSY) Increases By 243.2%
Fujitsu Limited (OTCMKTS:FJTSY – Get Free Report) was the target of a significant increase in short interest in November. As...
Coca-Cola Europacific Partners (LON:CCEP) Trading Down 1.7% – What’s Next?
Coca-Cola Europacific Partners PLC (LON:CCEP – Get Free Report) shares were down 1.7% during mid-day trading on Tuesday . The...
Bitcoin Depot Inc. (NASDAQ:BTM) Sees Large Increase in Short Interest
Bitcoin Depot Inc. (NASDAQ:BTM – Get Free Report) saw a significant growth in short interest in November. As of November...
X Financial (NYSE:XYF) Trading 6.2% Higher – What’s Next?
X Financial (NYSE:XYF – Get Free Report) rose 6.2% during mid-day trading on Tuesday . The stock traded as high...